CD152, Human (Tremelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD152, Human (Tremelimumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD152, Human (Tremelimumab biosimilar)
CloneTremelimumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG2 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD152 Recombinant Antibody (Tremelimumab). Tremelimumab (formerly ticilimumab, CP-675, 206) is a fully human monoclonal antibody against CTLA-4. It is an immune checkpoint blocker. Previously in development by Pfizer, it is now in investigation by MedImmune, a wholly owned subsidiary of AstraZeneca. It has been undergoing human trials for the treatment of various cancers but has not attained approval for any.
Immunogenn/a
Other NamesAnti-CD152 Recombinant Antibody, Research Grade Tremelimumab, Anti-Human CD152 Recombinant Antibody(Tremelimumab), CP-675, CP-675, 206, Antibody Drug Analogues, Monoclonal Antibody, YR1160, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 745013-59-6
Catalog #YR1160
Priceplease inquire
Order / More InfoCD152, Human (Tremelimumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.